Similar Papers

Paper Title
Journal
Date
Author
Real-world data on eculizumab treatment in NMOSD: high efficacy and potential challenges (P13-5.017)
...
Neurology | VOL. 100
, et. al. ...
25 Apr 2023
Identification of multiple sclerosis endophenotypes by high dimensional blood signatures associated with distinct disease trajectories (P1-3.008)
...
Neurology | VOL. 100
, et. al. ...
25 Apr 2023
Safety and Tolerability of Rimegepant Every Other Day for Preventive Treatment of Migraine Plus As-Needed for Acute Treatment of Migraine: Results from A 52-Week, Open-Label Extension Phase (P12-12.006)
Richard Lipton ... Christopher Jensen
Neurology | VOL. 100
Richard Lipton, et. al.Richard Lipton ... Christopher Jensen
25 Apr 2023
Diagnostic Value of the Boston criteria v2.0 for Cerebral Amyloid Angiopathy in Individuals Without Hemorrhage: An MRI-neuropathological Validation Study (S15.009)
Aaron Switzer ... Ronald Petersen
Neurology | VOL. 100
Aaron Switzer, et. al.Aaron Switzer ... Ronald Petersen
25 Apr 2023
View more papers

More From: Neurology

Paper Title
Journal
Date
Author
Reader Response: Distribution of Silent Cerebral Infarcts in Adults With Sickle Cell Disease
Calixto Machado
Neurology | VOL. -
Calixto MachadoCalixto Machado
28 Jan 2025
Brain Hypertrophy in Patients With Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis and Its Clinical Correlates
Richard Zubal ... Marian Galovic
Neurology | VOL. 104
Richard Zubal, et. al.Richard Zubal ... Marian Galovic
28 Jan 2025
Reader Response: Wall-Eyed Bilateral Internuclear Ophthalmoplegia Variant Syndrome Caused by Isolated Left Thalamic Infarction.
Eric R Eggenberger
Neurology | VOL. 104
Eric R EggenbergerEric R Eggenberger
28 Jan 2025
Editors' Note: Distribution of Silent Cerebral Infarcts in Adults With Sickle Cell Disease
Aravind Ganesh ... Steven L Galetta
Neurology | VOL. -
Aravind Ganesh, et. al.Aravind Ganesh ... Steven L Galetta
28 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.